ONCY (STOCKS)
Oncolytics Biotech, Inc. Common Shares
$0.805100
+0.005100 (+0.64%)
Prev close: $0.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jared Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $104.89M
- Employees
- 28
- P/E (TTM)
- -3.06
- P/B (TTM)
- -16.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.14 | $-0.10 | -0.0425 | -43.53% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.11 | +0.0377 | +35.00% |
|
Mar 2025 (Q1)
|
$-0.08 | $-0.10 | +0.0210 | +20.79% |
|
Dec 2024 (Q4)
|
$-0.10 | $-0.12 | +0.0231 | +18.77% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $37.71M |
| Research and Development | $17.41M |
| Other Operating Expenses | $20.30M |
| Operating Income/Loss | -$37.71M |
| Income/Loss From Continuing Operations After Tax | -$37.46M |
| Income/Loss From Continuing Operations Before Tax | -$37.34M |
| Income Tax Expense/Benefit | $119.00K |
| Net Income/Loss | -$37.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$37.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.35 |
| Diluted Earnings Per Share | -$0.35 |
| Basic Average Shares | 240,056,561 |
| Diluted Average Shares | 240,056,561 |
| Assets | $7.67M |
| Current Assets | $7.07M |
| Prepaid Expenses | $1.74M |
| Other Current Assets | $5.33M |
| Noncurrent Assets | $602.00K |
| Fixed Assets | $202.00K |
| Other Non-current Assets | $400.00K |
| Liabilities | $13.84M |
| Current Liabilities | $5.23M |
| Accounts Payable | $3.41M |
| Other Current Liabilities | $1.82M |
| Noncurrent Liabilities | $8.61M |
| Equity | -$6.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$6.17M |
| Liabilities And Equity | $7.67M |
| Net Cash Flow From Operating Activities | -$26.70M |
| Net Cash Flow From Operating Activities, Continuing | -$26.70M |
| Net Cash Flow From Investing Activities | -$11.00K |
| Net Cash Flow From Investing Activities, Continuing | -$11.00K |
| Net Cash Flow From Financing Activities | $20.23M |
| Net Cash Flow From Financing Activities, Continuing | $20.23M |
| Exchange Gains/Losses | -$119.00K |
| Net Cash Flow | -$6.61M |
| Net Cash Flow, Continuing | -$6.49M |
| Comprehensive Income/Loss | -$37.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.67M |
| Other Comprehensive Income/Loss | -$37.67M |